Product Information
POTASSIUM CITRATE ER 15 MEQ TB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1804 per EA under NDC 31722013201. Its NADAC has been published 277 times since May 5, 2021.
FDA first approved this application on Feb 5, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 meq/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722013201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA214420FDA Approved
2/5/2021
TE Code
AB
On Market Since
2/15/2021
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 15 MEQ TB has been published 277 times since May 5, 2021, and over the history we have for it it has declined 82.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1804 per EA |
|---|---|
| All-time high | $1.0595 (Jun 16, 2021) |
| All-time low | $0.1722 (Jul 17, 2024) |
| 52-week high | $0.2197 |
| 52-week low | $0.1796 |
| Median price | $0.2709 |
| Average price | $0.4001 |
| Largest weekly change | +69.2% (May 17, 2023) |
| Weeks tracked | 277 |
| Tracking since | May 5, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 15 MEQ TB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 15 MEQ TB, manufactured by Camber Pharmaceuticals Inc., is $0.1804 per EA (NDC 31722013201), effective Aug 19, 2026.
How has the price of POTASSIUM CITRATE ER 15 MEQ TB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has declined 82.6%. It has been tracked across 277 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 15 MEQ TB?
Since May 5, 2021, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has ranged from a low of $0.1722 (Jul 17, 2024) to a high of $1.0595 (Jun 16, 2021), with a median of $0.2709 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 15 MEQ TB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CITRATE ER 15 MEQ TB in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CITRATE ER 15 MEQ TB?
POTASSIUM CITRATE ER 15 MEQ TB (NDC 31722013201) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.